NASDAQ:MASS 908 Devices (MASS) Stock Price, News & Analysis $7.28 +0.16 (+2.25%) Closing price 04:00 PM EasternExtended Trading$7.26 -0.02 (-0.21%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About 908 Devices Stock (NASDAQ:MASS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get 908 Devices alerts:Sign Up Key Stats Today's Range$7.21▼$7.4750-Day Range$5.75▼$8.1752-Week Range$4.61▼$9.34Volume182,256 shsAverage Volume269,101 shsMarket Capitalization$275.26 millionP/E RatioN/ADividend YieldN/APrice Target$12.00Consensus RatingHold Company Overview 908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment. Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations. These platforms are designed to offer fast sample-to-answer workflows with integrated data analysis software. Founded in 2004 and headquartered in Boston, Massachusetts, 908 Devices leverages its proprietary micro-engineering and analytical expertise to serve customers around the world. The company’s instruments are employed across North America, Europe, Asia and other regions through a combination of direct sales, channel partners and strategic alliances. The company’s solutions support a variety of applications, including security and defense screening, forensic investigations, environmental monitoring, pharmaceutical quality control and food safety testing. By providing real-time chemical intelligence at the point of need, 908 Devices aims to enhance operational efficiency and safety for government agencies, research institutions and commercial laboratories.AI Generated. May Contain Errors. Read More 908 Devices Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreMASS MarketRank™: 908 Devices scored higher than 39% of companies evaluated by MarketBeat, and ranked 666th out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus Rating908 Devices has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside Potential908 Devices has a consensus price target of $12.00, representing about 64.8% upside from its current price of $7.28.Amount of Analyst Coverage908 Devices has only been the subject of 1 research reports in the past 90 days.Read more about 908 Devices' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for 908 Devices are expected to grow in the coming year, from ($0.38) to ($0.30) per share.Price to Book Value per Share Ratio908 Devices has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about 908 Devices' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.81% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 15.09, which indicates bearish sentiment.Change versus previous monthShort interest in 908 Devices has recently increased by 0.02%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend Yield908 Devices does not currently pay a dividend.Dividend Growth908 Devices does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment1.12 News Sentiment908 Devices has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for 908 Devices this week, compared to 3 articles on an average week. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, 908 Devices insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $668,032.00 in company stock.Percentage Held by Insiders28.20% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about 908 Devices' insider trading history. Receive MASS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MASS Stock News Headlines908 Devices Looking Better Now (Rating Upgrade)May 18, 2026 | seekingalpha.comCritical Survey: 908 Devices (NASDAQ:MASS) versus WORK Medical Technology Group (NASDAQ:WOK)May 16, 2026 | americanbankingnews.comThe chokepoint supplier behind SpaceX's $1.75 trillion empireWhen Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.May 22 at 1:00 AM | Behind the Markets (Ad)908 Devices (MASS) price target increased by 10.00% to 11.22May 14, 2026 | msn.com908 Devices Earnings Call Signals Profitable Growth PathMay 7, 2026 | tipranks.com908 Devices MASS Q1 2026 Earnings TranscriptMay 7, 2026 | finance.yahoo.com908 Devices Inc. (MASS) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.com908 Devices (NASDAQ:MASS) SVP Sells $53,185.21 in StockMay 5, 2026 | insidertrades.comSee More Headlines MASS Stock Analysis - Frequently Asked Questions How have MASS shares performed this year? 908 Devices' stock was trading at $5.25 at the start of the year. Since then, MASS stock has increased by 38.7% and is now trading at $7.28. How were 908 Devices' earnings last quarter? 908 Devices Inc. (NASDAQ:MASS) released its quarterly earnings results on Tuesday, March, 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.06) by $0.01. The firm had revenue of $17.38 million for the quarter, compared to analyst estimates of $16.19 million. 908 Devices had a negative trailing twelve-month return on equity of 14.03% and a negative net margin of 62.40%. Read the conference call transcript. When did 908 Devices IPO? 908 Devices (MASS) raised $120 million in an IPO on Friday, December 18th 2020. The company issued 6,500,000 shares at $18.00-$19.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO. Who are 908 Devices' major shareholders? Top institutional shareholders of 908 Devices include First Light Asset Management LLC (16.06%), Granahan Investment Management LLC (1.84%), Amova Asset Management Americas Inc. (0.72%) and Sumitomo Mitsui Trust Group Inc. (0.72%). Insiders that own company stock include Christopher D Brown, Kevin J Knopp, Joseph H Iv Griffith, John Kenneweg, Mark Spoto, Kevin J Mccallion and Michael S Turner. View institutional ownership trends. How do I buy shares of 908 Devices? Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of 908 Devices own? Based on aggregate information from My MarketBeat watchlists, some other companies that 908 Devices investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings3/03/2026Today5/22/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 MASS's financial health is in the Green zone, according to TradeSmith. MASS has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:MASS CIK1555279 Webwww.908devices.com Phone857-254-1500FaxN/AEmployees60Year Founded2012Price Target and Rating Average Price Target for 908 Devices$12.00 High Price Target$12.00 Low Price Target$12.00 Potential Upside/Downside+64.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($1.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$19.49 million Net Margins-62.40% Pretax Margin-61.35% Return on Equity-14.03% Return on Assets-10.40% Debt Debt-to-Equity RatioN/A Current Ratio3.58 Quick Ratio3.25 Sales & Book Value Annual Sales$56.20 million Price / Sales4.90 Cash FlowN/A Price / Cash FlowN/A Book Value$3.55 per share Price / Book2.05Miscellaneous Outstanding Shares37,810,000Free Float27,150,000Market Cap$275.26 million OptionableOptionable Beta0.57 Social Links The 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:MASS) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredOne algorithm, 17 years, nearly 2,000% total returnsA physicist in Dublin claims his AI algorithm has beaten the market for 17 consecutive years - with nearly 2,0...Porter & Company | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSystem failure: The strongest leverage for gold…$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredRevealed: The Best Kept Secrets On Wall StreetTom Busby, founder of the Diversified Trading Institute, is giving away his 'Little Black Book' - a collection...DTI Trader | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 908 Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
